טוען...
Novel Retinoic Acid Derivative Induces Differentiation and Growth Arrest in Neuroblastoma
INTRODUCTION: Retinoic acid (RA) is a differentiating agent utilized as maintenance therapy for high-risk neuroblastoma (NB), but associated toxicities limit its use. We have previously shown that a non-toxic, novel rexinoid, 9-cis-UAB30 (UAB30), decreased NB cell proliferation and in vivo tumor gro...
שמור ב:
| הוצא לאור ב: | J Pediatr Surg |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7299742/ https://ncbi.nlm.nih.gov/pubmed/32164984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2020.02.027 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|